Gottlieb: How a cultural shift is transforming FDA’s drug reviews

A decade ago, the FDA secured new tools, resources, and authorities to implement a watershed change in how the agency approached the drug review process.

The novel framework turned on a more active approach to managing drug safety, based on new authorities that the FDA sought and secured, to require drugmakers to impose requirements on doctors to assure the safe use of certain riskier drugs.